For HCC, chlorogenic acid could inhibit the proliferation of HepG2 cells in vitro and the progression of HepG2 xenograft in vivo, with the inactivation of ERK1/2 and downregulation of MMP2 and MMP9 [269]. The gene discussed is MMP9; the disease is hepatocellular carcinoma.